KLRS · Kalaris Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Ansbert Gadicke Director | ▲ Buy | Grant | 16,674,766 Shares held | 7/28/2022 | View profile |
| ElevateBio, LLC Director | ▲ Buy | Grant | 16,674,766 Shares held | 7/28/2022 | View profile |
| Vera Juan Chief Scientific Officer & COO | ▲ Buy | Grant | 2,409,928 Shares held | 6/6/2024 | View profile |
| Hallal David Chief Executive Officer | ▲ Buy | Grant | 2,143,662 Shares held | 6/6/2024 | View profile |
| Brainard Diana Director | ▼ Sell | Open Market | 723,363 Shares held | 11/19/2024 | View profile |
| Napoleone Ferrara | ▲ Buy | Grant | 504,000 Shares held | 3/18/2025 | View profile |
| Melian Agustin Chief Medical Officer | ▼ Sell | Open Market | 453,529 Shares held | 10/4/2021 | View profile |
| VAN BEEK JEROEN B Chief Commercial Officer | ▼ Sell | Open Market | 333,726 Shares held | 11/16/2022 | View profile |
| Piccina Cintia U.S. CCO & Country Gen Manager | ▲ Buy | Grant | 147,000 Shares held | 7/3/2023 | View profile |
| Atillasoy Ercem See Remarks | ▼ Sell | Open Market | 131,372 Shares held | 10/20/2022 | View profile |
| Leen Ann M. Chief Scientific Officer | ▲ Buy | Grant | 124,006 Shares held | 2/2/2023 | View profile |
| Bornstein Jeffrey S Director | ▲ Buy | Grant | 110,197 Shares held | 6/6/2024 | View profile |
| Samir Chandrakant Patel | ▲ Buy | Grant | 100,800 Shares held | 3/18/2025 | View profile |
| Jovan-Embiricos Morana 10% Owner | ▲ Buy | Grant | 100,197 Shares held | 6/6/2024 | View profile |
| Brenner Malcolm Director | ▲ Buy | Grant | 100,197 Shares held | 6/6/2024 | View profile |
| Shawn Tomasello Director | ▲ Buy | Grant | 70,000 Shares held | 6/6/2024 | View profile |
| Adams Derek N. Director | ▲ Buy | Grant | 70,000 Shares held | 6/6/2024 | View profile |
| Vikas Sinha Chief Financial Officer | ▼ Sell | Open Market | 49,129 Shares held | 2/21/2025 | View profile |
| Srinivas Akkaraju Director | ▼ Sell | Other | 19,408 Shares held | 5/20/2026 | View profile |
| Edward Miller General Counsel | ▼ Sell | Open Market | 6,517 Shares held | 2/21/2025 | View profile |
| Matthew Feinsod Chief Medical Officer | ▲ Buy | Grant | 4,030 Shares held | 3/18/2025 | View profile |
| Brett R. Hagen Chief Accounting Officer | ▼ Sell | Open Market | 0 Shares held | 3/20/2026 | View profile |
Transaction History
| Srinivas Akkaraju | ▲ Buy | Open Market | 244,300 | $1.2M | 5/20/2026 |
| Srinivas Akkaraju | ▼ Sell | Other | 66,906 | $0 | 5/20/2026 |
| Srinivas Akkaraju | ▼ Sell | Other | 14,937 | $0 | 5/20/2026 |
| Srinivas Akkaraju | ▼ Sell | Other | 4,471 | $0 | 5/20/2026 |
| Brett R. Hagen | ▼ Sell | Open Market | 1,915 | $13K | 3/20/2026 |
| Srinivas Akkaraju | ▲ Buy | Grant | 1,500,000 | $15.0M | 12/22/2025 |
| Srinivas Akkaraju | ▲ Buy | Open Market | 479,847 | $5.0M | 12/18/2025 |
| Brett R. Hagen | ▼ Sell | Open Market | 907 | $8K | 3/26/2025 |
| Napoleone Ferrara | ▲ Buy | Grant | 504,000 | — | 3/18/2025 |
| Samir Chandrakant Patel | ▲ Buy | Grant | 252,000 | — | 3/18/2025 |
| Samir Chandrakant Patel | ▲ Buy | Grant | 100,800 | — | 3/18/2025 |
| Matthew Feinsod | ▲ Buy | Grant | 4,030 | — | 3/18/2025 |
| Srinivas Akkaraju | ▲ Buy | Grant | 11,444,503 | — | 3/18/2025 |
| Vikas Sinha | ▼ Sell | Open Market | 303 | $3K | 2/21/2025 |
| Brett R. Hagen | ▼ Sell | Open Market | 96 | $967 | 2/21/2025 |
| Edward Miller | ▼ Sell | Open Market | 106 | $1K | 2/21/2025 |
| Vikas Sinha | ▼ Sell | Open Market | 116 | $1K | 1/23/2025 |
| Vikas Sinha | ▼ Sell | Open Market | 13 | $129 | 1/23/2025 |
| Edward Miller | ▼ Sell | Open Market | 47 | $444 | 1/23/2025 |
| Edward Miller | ▼ Sell | Open Market | 5 | $50 | 1/23/2025 |
| Brett R. Hagen | ▼ Sell | Open Market | 32 | $303 | 1/23/2025 |
| Brett R. Hagen | ▼ Sell | Open Market | 4 | $40 | 1/23/2025 |
| Brett R. Hagen | ▼ Sell | Open Market | 332 | $146 | 1/10/2025 |
| Vikas Sinha | ▼ Sell | Open Market | 979 | $431 | 1/10/2025 |
| Edward Miller | ▼ Sell | Open Market | 409 | $180 | 1/10/2025 |
| Edward Miller | ▼ Sell | Gift | 57,549 | $0 | 12/11/2024 |
| Edward Miller | ▼ Sell | Gift | 57,549 | $0 | 12/11/2024 |
| Brainard Diana | ▼ Sell | Open Market | 8,706 | $5K | 11/19/2024 |
| Brett R. Hagen | ▼ Sell | Open Market | 554 | $304 | 11/19/2024 |
| Vikas Sinha | ▼ Sell | Open Market | 3,186 | $2K | 11/19/2024 |
| Edward Miller | ▼ Sell | Open Market | 432 | $237 | 11/19/2024 |
| Vikas Sinha | ▼ Sell | Open Market | 5,136 | $4K | 11/5/2024 |
| Brainard Diana | ▼ Sell | Open Market | 10,609 | $9K | 11/5/2024 |
| Brett R. Hagen | ▼ Sell | Open Market | 1,655 | $1K | 11/5/2024 |
| Edward Miller | ▼ Sell | Open Market | 2,272 | $2K | 11/5/2024 |
| Edward Miller | ▼ Sell | Open Market | 766 | $588 | 10/22/2024 |
| Brett R. Hagen | ▼ Sell | Open Market | 486 | $373 | 10/22/2024 |
| Vikas Sinha | ▼ Sell | Open Market | 1,882 | $1K | 10/22/2024 |
| Brainard Diana | ▼ Sell | Open Market | 9,752 | $8K | 10/21/2024 |
| Brett R. Hagen | ▼ Sell | Open Market | 479 | $373 | 10/21/2024 |
| Edward Miller | ▼ Sell | Open Market | 635 | $495 | 10/21/2024 |
| Vikas Sinha | ▼ Sell | Open Market | 1,546 | $1K | 10/21/2024 |
| Vikas Sinha | ▼ Sell | Open Market | 940 | $766 | 10/3/2024 |
| Brainard Diana | ▼ Sell | Open Market | 1,493 | $1K | 10/3/2024 |
| Brett R. Hagen | ▼ Sell | Open Market | 301 | $245 | 10/3/2024 |
| Edward Miller | ▼ Sell | Open Market | 377 | $307 | 10/3/2024 |
| Brainard Diana | ▼ Sell | Open Market | 5,390 | $4K | 8/20/2024 |
| Brett R. Hagen | ▼ Sell | Open Market | 544 | $413 | 8/19/2024 |
| Vikas Sinha | ▼ Sell | Open Market | 3,159 | $2K | 8/19/2024 |
| Edward Miller | ▼ Sell | Open Market | 422 | $321 | 8/19/2024 |
| Brainard Diana | ▼ Sell | Open Market | 3,091 | $2K | 8/19/2024 |
| Edward Miller | ▼ Sell | Open Market | 2,323 | $2K | 8/5/2024 |
| Brainard Diana | ▼ Sell | Open Market | 10,847 | $8K | 8/5/2024 |
| Vikas Sinha | ▼ Sell | Open Market | 5,251 | $4K | 8/5/2024 |
| Brett R. Hagen | ▼ Sell | Open Market | 1,692 | $1K | 8/5/2024 |
| Brett R. Hagen | ▼ Sell | Open Market | 481 | $356 | 7/22/2024 |
| Vikas Sinha | ▼ Sell | Open Market | 1,858 | $1K | 7/22/2024 |
| Edward Miller | ▼ Sell | Open Market | 757 | $560 | 7/22/2024 |
| Vikas Sinha | ▼ Sell | Open Market | 1,542 | $1K | 7/19/2024 |
| Brett R. Hagen | ▼ Sell | Open Market | 479 | $359 | 7/19/2024 |
| Brainard Diana | ▼ Sell | Open Market | 9,731 | $7K | 7/19/2024 |
| Edward Miller | ▼ Sell | Open Market | 634 | $476 | 7/19/2024 |
| Edward Miller | ▼ Sell | Open Market | 379 | $273 | 7/2/2024 |
| Vikas Sinha | ▼ Sell | Open Market | 939 | $676 | 7/2/2024 |
| Brett R. Hagen | ▼ Sell | Open Market | 304 | $219 | 7/2/2024 |
| Brainard Diana | ▼ Sell | Open Market | 1,489 | $1K | 7/2/2024 |
| Bornstein Jeffrey S | ▲ Buy | Grant | 35,000 | $0 | 6/6/2024 |
| Jovan-Embiricos Morana | ▲ Buy | Grant | 35,000 | $0 | 6/6/2024 |
| Adams Derek N. | ▲ Buy | Grant | 35,000 | $0 | 6/6/2024 |
| Hallal David | ▲ Buy | Grant | 35,000 | $0 | 6/6/2024 |
| Vera Juan | ▲ Buy | Grant | 35,000 | $0 | 6/6/2024 |
| Shawn Tomasello | ▲ Buy | Grant | 35,000 | $0 | 6/6/2024 |
| Brenner Malcolm | ▲ Buy | Grant | 35,000 | $0 | 6/6/2024 |
| Brainard Diana | ▼ Sell | Open Market | 5,149 | $4K | 5/21/2024 |
| Vikas Sinha | ▼ Sell | Open Market | 3,143 | $2K | 5/17/2024 |
| Edward Miller | ▼ Sell | Open Market | 420 | $315 | 5/17/2024 |
| Brett R. Hagen | ▼ Sell | Open Market | 541 | $405 | 5/17/2024 |
| Brainard Diana | ▼ Sell | Open Market | 3,075 | $2K | 5/17/2024 |
| Edward Miller | ▼ Sell | Open Market | 2,311 | $2K | 5/3/2024 |
| Vikas Sinha | ▼ Sell | Open Market | 4,957 | $4K | 5/3/2024 |
| Brainard Diana | ▼ Sell | Open Market | 10,240 | $8K | 5/3/2024 |
| Brett R. Hagen | ▼ Sell | Open Market | 1,597 | $1K | 5/3/2024 |
| Vikas Sinha | ▼ Sell | Open Market | 1,857 | $1K | 4/22/2024 |
| Edward Miller | ▼ Sell | Open Market | 757 | $568 | 4/22/2024 |
| Brett R. Hagen | ▼ Sell | Open Market | 480 | $360 | 4/22/2024 |
| Brett R. Hagen | ▼ Sell | Open Market | 473 | $355 | 4/19/2024 |
| Edward Miller | ▼ Sell | Open Market | 626 | $470 | 4/19/2024 |
| Vikas Sinha | ▼ Sell | Open Market | 1,521 | $1K | 4/19/2024 |
| Brainard Diana | ▼ Sell | Open Market | 9,601 | $7K | 4/19/2024 |
| Edward Miller | ▼ Sell | Open Market | 368 | $284 | 4/2/2024 |
| Brainard Diana | ▼ Sell | Open Market | 1,533 | $1K | 4/2/2024 |
| Brett R. Hagen | ▼ Sell | Open Market | 281 | $217 | 4/2/2024 |
| Vikas Sinha | ▼ Sell | Open Market | 885 | $683 | 4/2/2024 |
| Brainard Diana | ▼ Sell | Open Market | 5,155 | $4K | 2/21/2024 |
| Edward Miller | ▼ Sell | Open Market | 385 | $268 | 2/20/2024 |
| Vikas Sinha | ▼ Sell | Open Market | 2,893 | $2K | 2/20/2024 |
| Brett R. Hagen | ▼ Sell | Open Market | 494 | $343 | 2/20/2024 |
| Brainard Diana | ▼ Sell | Open Market | 3,097 | $2K | 2/20/2024 |
| Brett R. Hagen | ▼ Sell | Open Market | 11,150 | $7K | 2/8/2024 |
| Vikas Sinha | ▼ Sell | Open Market | 18,331 | $12K | 2/5/2024 |
| Brett R. Hagen | ▼ Sell | Open Market | 5,792 | $4K | 2/5/2024 |
| Edward Miller | ▼ Sell | Open Market | 8,869 | $6K | 2/5/2024 |
| Brainard Diana | ▼ Sell | Open Market | 41,421 | $28K | 2/5/2024 |
| Vikas Sinha | ▼ Sell | Open Market | 3,205 | $2K | 1/23/2024 |
| Brainard Diana | ▼ Sell | Open Market | 9,500 | $6K | 1/23/2024 |
| Brett R. Hagen | ▼ Sell | Open Market | 901 | $604 | 1/23/2024 |
| Edward Miller | ▼ Sell | Open Market | 1,302 | $873 | 1/23/2024 |
| Brett R. Hagen | ▼ Sell | Open Market | 310 | $198 | 1/4/2024 |
| Edward Miller | ▼ Sell | Open Market | 424 | $271 | 1/4/2024 |
| Vikas Sinha | ▼ Sell | Open Market | 961 | $614 | 1/4/2024 |
| Brainard Diana | ▼ Sell | Open Market | 1,664 | $1K | 1/4/2024 |
| Brett R. Hagen | ▼ Sell | Open Market | 28,335 | $21K | 12/27/2023 |
| Brainard Diana | ▼ Sell | Open Market | 4,382 | $7K | 11/20/2023 |
| Vikas Sinha | ▼ Sell | Open Market | 2,490 | $4K | 11/17/2023 |
| Brett R. Hagen | ▼ Sell | Open Market | 403 | $657 | 11/17/2023 |
| Brainard Diana | ▼ Sell | Open Market | 2,689 | $4K | 11/17/2023 |
| Brett R. Hagen | ▼ Sell | Open Market | 357 | $550 | 10/20/2023 |
| Vikas Sinha | ▼ Sell | Open Market | 1,475 | $2K | 10/20/2023 |
| Brett R. Hagen | ▼ Sell | Open Market | 358 | $566 | 10/19/2023 |
| Brainard Diana | ▼ Sell | Open Market | 8,581 | $14K | 10/19/2023 |
| Vikas Sinha | ▼ Sell | Open Market | 1,232 | $2K | 10/19/2023 |
| Brainard Diana | ▼ Sell | Open Market | 1,325 | $3K | 10/3/2023 |
| Vikas Sinha | ▼ Sell | Open Market | 755 | $1K | 10/3/2023 |
| Brett R. Hagen | ▼ Sell | Open Market | 222 | $439 | 10/3/2023 |
| Brainard Diana | ▼ Sell | Open Market | 4,055 | $11K | 8/18/2023 |
| Vikas Sinha | ▼ Sell | Open Market | 10,516 | $26K | 8/17/2023 |
| Brainard Diana | ▼ Sell | Open Market | 11,361 | $28K | 8/17/2023 |
| Brett R. Hagen | ▼ Sell | Open Market | 1,653 | $4K | 8/17/2023 |
| Brett R. Hagen | ▼ Sell | Open Market | 342 | $1K | 7/20/2023 |
| Vikas Sinha | ▼ Sell | Open Market | 1,437 | $5K | 7/20/2023 |
| Brainard Diana | ▼ Sell | Open Market | 8,342 | $30K | 7/19/2023 |
| Brett R. Hagen | ▼ Sell | Open Market | 342 | $1K | 7/19/2023 |
| Vikas Sinha | ▼ Sell | Open Market | 1,198 | $4K | 7/19/2023 |
| Brainard Diana | ▼ Sell | Open Market | 5,275 | $16K | 7/5/2023 |
| Vikas Sinha | ▼ Sell | Open Market | 2,983 | $9K | 7/5/2023 |
| Piccina Cintia | ▲ Buy | Grant | 147,000 | $0 | 7/3/2023 |
| Brett R. Hagen | ▼ Sell | Open Market | 5,045 | $28K | 6/9/2023 |
| Brainard Diana | ▼ Sell | Open Market | 4,536 | $19K | 5/18/2023 |
| Jovan-Embiricos Morana | ▲ Buy | Grant | 35,000 | $0 | 5/11/2023 |
| Shawn Tomasello | ▲ Buy | Grant | 35,000 | $0 | 5/11/2023 |
| Adams Derek N. | ▲ Buy | Grant | 35,000 | $0 | 5/11/2023 |
| Vera Juan | ▲ Buy | Grant | 35,000 | $0 | 5/11/2023 |
| Bornstein Jeffrey S | ▲ Buy | Grant | 35,000 | $0 | 5/11/2023 |
| Brenner Malcolm | ▲ Buy | Grant | 35,000 | $0 | 5/11/2023 |
| Hallal David | ▲ Buy | Grant | 35,000 | $0 | 5/11/2023 |
| Vikas Sinha | ▼ Sell | Open Market | 1,466 | $5K | 4/20/2023 |
| Brett R. Hagen | ▼ Sell | Open Market | 349 | $1K | 4/20/2023 |
| Vikas Sinha | ▼ Sell | Open Market | 1,217 | $5K | 4/19/2023 |
| Brett R. Hagen | ▼ Sell | Open Market | 348 | $1K | 4/19/2023 |
| Brainard Diana | ▼ Sell | Open Market | 8,408 | $31K | 4/19/2023 |
| Brainard Diana | ▼ Sell | Open Market | 5,122 | $34K | 2/21/2023 |
| Vikas Sinha | ▲ Buy | Grant | 157,500 | $0 | 2/2/2023 |
| Edward Miller | ▲ Buy | Grant | 87,500 | $0 | 2/2/2023 |
| Leen Ann M. | ▲ Buy | Grant | 43,750 | $0 | 2/2/2023 |
| Brett R. Hagen | ▲ Buy | Grant | 61,250 | $0 | 2/2/2023 |
| Brainard Diana | ▲ Buy | Grant | 332,500 | $0 | 2/2/2023 |
| Vikas Sinha | ▼ Sell | Open Market | 1,426 | $7K | 1/20/2023 |
| Edward Miller | ▼ Sell | Open Market | 541 | $3K | 1/20/2023 |
| Brett R. Hagen | ▼ Sell | Open Market | 338 | $2K | 1/20/2023 |
| Vikas Sinha | ▼ Sell | Open Market | 5,111 | $26K | 1/19/2023 |
| Edward Miller | ▼ Sell | Open Market | 2,032 | $10K | 1/19/2023 |
| Brett R. Hagen | ▼ Sell | Open Market | 1,557 | $8K | 1/19/2023 |
| Brainard Diana | ▼ Sell | Open Market | 34,435 | $175K | 1/19/2023 |
| Edward Miller | ▼ Sell | Gift | 98,346 | $0 | 12/2/2022 |
| Edward Miller | ▼ Sell | Gift | 98,346 | $0 | 12/2/2022 |
| Brainard Diana | ▼ Sell | Open Market | 4,515 | $33K | 11/18/2022 |
| VAN BEEK JEROEN B | ▼ Sell | Open Market | 16,074 | $121K | 11/16/2022 |
| Edward Miller | ▼ Sell | Open Market | 2,358 | $21K | 11/14/2022 |
| Brett R. Hagen | ▼ Sell | Open Market | 18,011 | $147K | 11/11/2022 |
| VAN BEEK JEROEN B | ▼ Sell | Open Market | 36,592 | $300K | 11/11/2022 |
| VAN BEEK JEROEN B | ▼ Sell | Open Market | 13,109 | $105K | 11/10/2022 |
| Brett R. Hagen | ▼ Sell | Open Market | 5,989 | $48K | 11/10/2022 |
| VAN BEEK JEROEN B | ▼ Sell | Open Market | 299 | $2K | 11/8/2022 |
| Brett R. Hagen | ▼ Sell | Open Market | 2,000 | $16K | 10/24/2022 |
| Brett R. Hagen | ▼ Sell | Open Market | 11,334 | $96K | 10/21/2022 |
| Atillasoy Ercem | ▼ Sell | Open Market | 1,527 | $13K | 10/20/2022 |
| Vikas Sinha | ▼ Sell | Open Market | 1,449 | $14K | 10/19/2022 |
| VAN BEEK JEROEN B | ▼ Sell | Open Market | 1,070 | $10K | 10/19/2022 |
| Brett R. Hagen | ▼ Sell | Open Market | 345 | $3K | 10/19/2022 |
| Edward Miller | ▼ Sell | Open Market | 553 | $5K | 10/19/2022 |
| Atillasoy Ercem | ▼ Sell | Open Market | 568 | $5K | 10/19/2022 |
| Hallal David | ▼ Sell | Open Market | 600,000 | $5.1M | 10/19/2022 |
| Hallal David | ▼ Sell | Open Market | 400,000 | $2.9M | 9/29/2022 |
| VAN BEEK JEROEN B | ▼ Sell | Open Market | 493 | $4K | 9/2/2022 |
| Brainard Diana | ▼ Sell | Open Market | 4,564 | $35K | 8/18/2022 |
| Leen Ann M. | ▲ Buy | Grant | 15,000 | $0 | 8/16/2022 |
| Vikas Sinha | ▲ Buy | Grant | 100,000 | $0 | 8/16/2022 |
| Edward Miller | ▲ Buy | Grant | 15,000 | $0 | 8/16/2022 |
| Brainard Diana | ▲ Buy | Grant | 100,000 | $0 | 8/16/2022 |
| VAN BEEK JEROEN B | ▼ Sell | Open Market | 15,590 | $129K | 8/16/2022 |
| VAN BEEK JEROEN B | ▲ Buy | Grant | 15,000 | $0 | 8/16/2022 |
| Brett R. Hagen | ▲ Buy | Grant | 20,000 | $0 | 8/16/2022 |
| Vikas Sinha | ▲ Buy | Grant | 3,253,796 | $15.0M | 7/28/2022 |
| Hallal David | ▲ Buy | Grant | 3,253,796 | $15.0M | 7/28/2022 |
| Jovan-Embiricos Morana | ▲ Buy | Grant | 684,622 | $3.2M | 7/28/2022 |
| Jovan-Embiricos Morana | ▲ Buy | Grant | 325,379 | $1.5M | 7/28/2022 |
| Jovan-Embiricos Morana | ▲ Buy | Grant | 1,626,898 | $7.5M | 7/28/2022 |
| Jovan-Embiricos Morana | ▲ Buy | Grant | 1,393,874 | $6.4M | 7/28/2022 |
| Jovan-Embiricos Morana | ▲ Buy | Grant | 867,678 | $4.0M | 7/28/2022 |
| Jovan-Embiricos Morana | ▲ Buy | Grant | 3,253,796 | $15.0M | 7/28/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Kalaris Therapeutics Moves in Pre-Market Amid Low RSI
Kalaris Therapeutics was highlighted in a roundup of health care stocks moving in Wednesday's pre-market session. The stock is currently trading near its 52-week low, with the RSI indicating oversold conditions. Analysts maintain a wide range of price targets for the company, reflecting varying views on its future performance.
Kalaris Therapeutics Moves in Pre-Market Amid Low RSI. Kalaris Therapeutics was highlighted in a roundup of health care stocks moving in Wednesday's pre-market session. The stock is currently trading near its 52-week low, with the RSI indicating oversold conditions. Analysts maintain a wide range of price targets for the company, reflecting varying views on its future performance.